Le Lézard
Classified in: Health, Science and technology, Business, Covid-19 virus
Subjects: EARNINGS, MISCELLANEOUS

MedMira Reports FY2021 Fourth Quarter and Year End Financial Results


HALIFAX, Nova Scotia, Nov. 30, 2021 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the financial year ended July 31, 2021.

Profit and Loss Highlights

Balance Sheet Highlights

The Company's financial statements and management's discussion and analysis are available on the Company's profile on SEDAR at www.sedar.com. For matters of going concern, reference is made to the Auditor's Emphasis of Matter statement in the fiscal year ended 2020 Auditors Report and note 2b in the audited financial statements which are also available on SEDAR.

About MedMira

MedMira is the developer and owner of Rapid Vertical Flow (RVF)® Technology. The Company's rapid test applications built on RVF Technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as HIV and hepatitis C in just three easy steps. The Company's tests are sold under the Reveal®, Multiplo® and Miriad® brands in global markets. MedMira's corporate offices and manufacturing facilities are located in Halifax, Nova Scotia, Canada and the Company has a sales and customer service office located in the United States. For more information visit medmira.com. Follow us on Twitter and LinkedIn.

This news release contains forward-looking statements, which involve risk and uncertainties and reflect the Company's current expectation regarding future events including statements regarding possible approval and launch of new products, future growth, and new business opportunities. Actual events could materially differ from those projected herein and depend on a number of factors including, but not limited to, changing market conditions, successful and timely completion of clinical studies, uncertainties related to the regulatory approval process, establishment of corporate alliances and other risks detailed from time to time in the company quarterly filings.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

MedMira Contacts:

Markus Meile, CFO                
Tel: 902-450-1588                
Email: [email protected]        



These press releases may also interest you

29 mar 2024
Frost & Sullivan recently researched the cybersecurity services industry and, based on its findings, recognizes Singtel with the 2023 Singapore Company of the Year Award. Singtel is Singapore's major telecommunications...

29 mar 2024
The "Europe Electric Vehicle Aftermarket: Analysis and Forecast, 2023-2032" report has been added to ResearchAndMarkets.com's offering.   The Europe electric vehicle aftermarket (excluding U.K) is projected to reach $50.66 billion by 2032 from $8.87...

29 mar 2024
The "Global DNA Methylation Detection Technology Market: Focus on Technology, Application, End User, Product Type, Country Level Analysis and Competitive Landscape - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's...

29 mar 2024
The "New Zealand Gift Card and Incentive Card Market Intelligence and Future Growth Dynamics (Databook) - Q1 2024 Update" report has been added to ResearchAndMarkets.com's offering. The gift card industry in New Zealand is expected to reach US$1...

29 mar 2024
The "Global Gift Card and Incentive Card Market Intelligence Databook Subscription - Q1 2024" report has been added to ResearchAndMarkets.com's offering. The global gift card industry is expected to reach US$555.8 billion in 2024 and will continue...

29 mar 2024
Among PaintScaping's notable past projects include collaborations with renowned artists such as Calvin Harris, Rihanna, Kelahni, Lil Yachty, Cardi B, 21 Savage, Zhu, Tame Impala, and Porter Robinson. In the Calvin Harris and Rihanna project,...



News published on and distributed by: